Getinge (OTCMKTS:GNGBY – Get Free Report) shares passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $23.09 and traded as low as $22.49. Getinge shares last traded at $22.4925, with a volume of 3,242 shares trading hands.
Wall Street Analysts Forecast Growth
Separately, Nordea Equity Research upgraded Getinge from a “hold” rating to a “buy” rating in a research report on Wednesday, October 22nd. One equities research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy”.
View Our Latest Analysis on Getinge
Getinge Stock Performance
Getinge (OTCMKTS:GNGBY – Get Free Report) last announced its quarterly earnings results on Tuesday, January 27th. The company reported $0.47 earnings per share (EPS) for the quarter. Getinge had a return on equity of 10.60% and a net margin of 6.54%.The firm had revenue of $1.08 billion during the quarter.
About Getinge
Getinge AB is a global medical technology company that develops, manufactures and markets products and systems for hospitals and life sciences institutions. The company’s offerings focus on critical care, surgical workflows and infection control, aiming to improve clinical outcomes and operational efficiency. Getinge’s solutions support a range of applications from intensive care and cardiovascular treatments to sterile reprocessing of surgical instruments.
The company’s product portfolio includes sterilization and disinfection equipment, surgical tables and lights, ventilation systems, heart-lung machines and extracorporeal membrane oxygenation (ECMO) devices.
Recommended Stories
- Five stocks we like better than Getinge
- Is THIS the Next Big Money Rush?
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Wall Street Legend Names #1 Stock of 2026 Live On-Camera
- ISPC: From Small Cap to Life Sciences Market Disruptor!
- The Crash Has Already Started (Most Just Don’t See It Yet)
Receive News & Ratings for Getinge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Getinge and related companies with MarketBeat.com's FREE daily email newsletter.
